Efficacy of MitraCLip Vs. PASCAL for the TrEAtment of MitraL REgurgiTation in an All-comer Population
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorLMU Klinikum
About this trial
To investigate potential differences in procedural outcomes of both commercially available transcatheter edge-to-edge mitral valve repair devices in a non-selected clinical setting.
Eligibility criteria
Qualifiers
Age equal or above 18 years
Written consent
Heart Team recommends M-TEER
Disqualifiers
Mitral Stenosis (MV mean PG > 5 mmHg)
Cardiogenic shock or hemodynamic instability at the time of intervention
Active endocarditis
Participant in another interventional cardiology study
Trial design
Treatments tested in this trial
- Transcatheter mitral valve edge-to-edge repair (M-TEER)
Treatment groups
180 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov